| 2025年中报 | 2024年年报 | 2024年中报 | 2024年一季报 | 2023年年报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 化学原料药(元) | 1,319,641,343.66 | 2,636,879,147.97 | - | - | 2,497,996,967.04 |
| 化学制剂药(元) | 2,250,983,647.56 | 4,344,748,634.78 | 2,404,042,672.60 | - | 4,300,505,911.39 |
| 生物制剂(元) | 881,590,490.87 | 1,614,342,888.88 | 804,110,127.59 | - | 1,593,271,510.53 |
| 医药及其它物流贸易(元) | 356,444,647.48 | 455,306,222.29 | 292,246,548.97 | - | 771,896,700.11 |
| 医药中间体(元) | 341,277,434.90 | 615,038,955.73 | 217,596,742.82 | 100,000,000.00 | 718,833,743.43 |
| 防疫类(元) | - | - | - | 329,000,000.00 | - |
| 抗感染类(元) | - | - | - | 1,371,000,000.00 | - |
| 农兽类(元) | - | - | - | 201,000,000.00 | - |
| 神经、血液系统用药(元) | - | - | - | 55,000,000.00 | - |
| 肾病及免疫调节类(元) | - | - | - | 120,000,000.00 | - |
| 维生素及健康消费品(元) | - | - | - | 53,000,000.00 | - |
| 心脑血管类(元) | - | - | - | 67,000,000.00 | - |
| 医药及其他物流贸易(元) | - | - | - | 127,000,000.00 | - |
| 化学原药(元) | - | - | 1,401,027,372.59 | - | - |
| 其他(元) | 78,777,354.03 | 131,497,811.86 | 84,956,774.96 | - | 187,374,974.41 |
| 其他类(元) | - | - | - | 122,000,000.00 | - |
| 营业成本(元) | |||||
| 化学原料药(元) | 1,164,626,737.83 | 2,313,952,254.51 | - | - | 2,228,255,261.44 |
| 化学制剂药(元) | 1,662,087,971.28 | 2,983,595,214.78 | 1,741,048,733.87 | - | 2,836,233,769.36 |
| 生物制剂(元) | 153,990,301.87 | 300,683,511.87 | 138,039,593.23 | - | 289,333,541.55 |
| 医药及其它物流贸易(元) | 351,197,322.27 | 445,073,134.95 | 287,307,210.12 | - | 764,944,409.05 |
| 医药中间体(元) | 293,217,177.92 | 522,884,148.96 | 206,313,450.09 | 85,000,000.00 | 585,555,472.03 |
| 防疫类(元) | - | - | - | 39,000,000.00 | - |
| 抗感染类(元) | - | - | - | 1,090,000,000.00 | - |
| 农兽类(元) | - | - | - | 169,000,000.00 | - |
| 神经、血液系统用药(元) | - | - | - | 28,000,000.00 | - |
| 肾病及免疫调节类(元) | - | - | - | 36,000,000.00 | - |
| 维生素及健康消费品(元) | - | - | - | 38,000,000.00 | - |
| 心脑血管类(元) | - | - | - | 46,000,000.00 | - |
| 医药及其他物流贸易(元) | - | - | - | 124,000,000.00 | - |
| 化学原药(元) | - | - | 1,198,167,455.04 | - | - |
| 其他(元) | 55,805,637.04 | 114,965,957.72 | 76,010,344.75 | - | 158,084,786.36 |
| 其他类(元) | - | - | - | 113,000,000.00 | - |
| 毛利(元) | |||||
| 化学原料药(元) | 155,014,605.83 | 322,926,893.46 | - | - | 269,741,705.60 |
| 化学制剂药(元) | 588,895,676.28 | 1,361,153,420.00 | 662,993,938.73 | - | 1,464,272,142.03 |
| 生物制剂(元) | 727,600,189.00 | 1,313,659,377.01 | 666,070,534.36 | - | 1,303,937,968.98 |
| 医药及其它物流贸易(元) | 5,247,325.21 | 10,233,087.34 | 4,939,338.85 | - | 6,952,291.06 |
| 医药中间体(元) | 48,060,256.98 | 92,154,806.77 | 11,283,292.73 | 15,000,000.00 | 133,278,271.40 |
| 防疫类(元) | - | - | - | 290,000,000.00 | - |
| 抗感染类(元) | - | - | - | 281,000,000.00 | - |
| 农兽类(元) | - | - | - | 32,000,000.00 | - |
| 神经、血液系统用药(元) | - | - | - | 27,000,000.00 | - |
| 肾病及免疫调节类(元) | - | - | - | 84,000,000.00 | - |
| 维生素及健康消费品(元) | - | - | - | 15,000,000.00 | - |
| 心脑血管类(元) | - | - | - | 21,000,000.00 | - |
| 医药及其他物流贸易(元) | - | - | - | 3,000,000.00 | - |
| 化学原药(元) | - | - | 202,859,917.55 | - | - |
| 其他(元) | 22,971,716.99 | 16,531,854.14 | 8,946,430.21 | - | 29,290,188.05 |
| 其他类(元) | - | - | - | 9,000,000.00 | - |
| 毛利率(%) | |||||
| 化学原料药(%) | 11.75 | 12.25 | - | - | 10.80 |
| 化学制剂药(%) | 26.16 | 31.33 | 27.58 | - | 34.05 |
| 生物制剂(%) | 82.53 | 81.37 | 82.83 | - | 81.84 |
| 医药及其它物流贸易(%) | 1.47 | 2.25 | 1.69 | - | 0.90 |
| 医药中间体(%) | 14.08 | 14.98 | 5.19 | 15.00 | 18.54 |
| 防疫类(%) | - | - | - | 88.15 | - |
| 抗感染类(%) | - | - | - | 20.50 | - |
| 农兽类(%) | - | - | - | 15.92 | - |
| 神经、血液系统用药(%) | - | - | - | 49.09 | - |
| 肾病及免疫调节类(%) | - | - | - | 70.00 | - |
| 维生素及健康消费品(%) | - | - | - | 28.30 | - |
| 心脑血管类(%) | - | - | - | 31.34 | - |
| 医药及其他物流贸易(%) | - | - | - | 2.36 | - |
| 化学原药(%) | - | - | 14.48 | - | - |
| 其他(%) | 29.16 | 12.57 | 10.53 | - | 15.63 |
| 其他类(%) | - | - | - | 7.38 | - |
| 收入构成(%) | |||||
| 化学原料药(%) | 25.24 | 26.91 | - | - | 24.81 |
| 化学制剂药(%) | 43.05 | 44.34 | 46.20 | - | 42.71 |
| 生物制剂(%) | 16.86 | 16.48 | 15.45 | - | 15.82 |
| 医药及其它物流贸易(%) | 6.82 | 4.65 | 5.62 | - | 7.67 |
| 医药中间体(%) | 6.53 | 6.28 | 4.18 | 3.93 | 7.14 |
| 防疫类(%) | - | - | - | 12.93 | - |
| 抗感染类(%) | - | - | - | 53.87 | - |
| 农兽类(%) | - | - | - | 7.90 | - |
| 神经、血液系统用药(%) | - | - | - | 2.16 | - |
| 肾病及免疫调节类(%) | - | - | - | 4.72 | - |
| 维生素及健康消费品(%) | - | - | - | 2.08 | - |
| 心脑血管类(%) | - | - | - | 2.63 | - |
| 医药及其他物流贸易(%) | - | - | - | 4.99 | - |
| 化学原药(%) | - | - | 26.92 | - | - |
| 其他(%) | 1.51 | 1.34 | 1.63 | - | 1.86 |
| 其他类(%) | - | - | - | 4.79 | - |
| 毛利构成(%) | |||||
| 化学原料药(%) | 10.02 | 10.36 | - | - | 8.41 |
| 化学制剂药(%) | 38.05 | 43.67 | 42.58 | - | 45.65 |
| 生物制剂(%) | 47.01 | 42.15 | 42.78 | - | 40.65 |
| 医药及其它物流贸易(%) | 0.34 | 0.33 | 0.32 | - | 0.22 |
| 医药中间体(%) | 3.11 | 2.96 | 0.72 | 1.93 | 4.16 |
| 防疫类(%) | - | - | - | 37.32 | - |
| 抗感染类(%) | - | - | - | 36.16 | - |
| 农兽类(%) | - | - | - | 4.12 | - |
| 神经、血液系统用药(%) | - | - | - | 3.47 | - |
| 肾病及免疫调节类(%) | - | - | - | 10.81 | - |
| 维生素及健康消费品(%) | - | - | - | 1.93 | - |
| 心脑血管类(%) | - | - | - | 2.70 | - |
| 医药及其他物流贸易(%) | - | - | - | 0.39 | - |
| 化学原药(%) | - | - | 13.03 | - | - |
| 其他(%) | 1.48 | 0.53 | 0.57 | - | 0.91 |
| 其他类(%) | - | - | - | 1.16 | - |